Quoin Pharmaceuticals Ltd (QNRX)

Stock price, financials, and technical signals for Quoin Pharmaceuticals Ltd (QNRX).

$0.33

0.04

(15.22%)

As of 01/31/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

QNRX Performance Snapshot


1-Week Chg

-12.60%

1-Month Chg

-48.85%

3-Month Chg

-55.42%

6-Month Chg

-44.50%

1-Year Chg

-90.67%

Year-To-Date Chg

-50.37%

Beta 1-Year

-0.29

Beta 5-Year

1.81

Volatility (10-Day)

28.83%

QNRX Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-01-31

$0.33

$0.04 (15.22%)

$0.29

$0.38

$0.29

$0.34

4.37M ($1.46M)

2025-01-30

$0.29

-$0.02 (-6.77%)

$0.32

$0.32

$0.28

$0.29

1.21M ($349.92K)

2025-01-29

$0.31

-$0.01 (-3.13%)

$0.31

$0.33

$0.30

$0.31

698.11K ($216.41K)

2025-01-28

$0.32

-$0.02 (-6.16%)

$0.33

$0.33

$0.31

$0.32

1.75M ($560.86K)

2025-01-27

$0.34

-$0.04 (-10.5%)

$0.36

$0.37

$0.34

$0.35

2.35M ($800.84K)

2025-01-24

$0.38

-$0.03 (-7.3%)

$0.37

$0.43

$0.36

$0.39

6.30M ($2.40M)

2025-01-23

$0.41

-$0.18 (-30.34%)

$0.67

$0.67

$0.40

$0.49

61.05M ($25.09M)

2025-01-22

$0.59

-$0.02 (-3.91%)

$0.60

$0.61

$0.57

$0.59

329.45K ($194.38K)

2025-01-21

$0.61

$0.04 (7.53%)

$0.60

$0.63

$0.56

$0.60

141.18K ($86.68K)

2025-01-17

$0.57

-$0.02 (-3.22%)

$0.58

$0.60

$0.57

$0.58

117.66K ($67.19K)

QNRX Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $3.12M

    -1.48%

  • Total assets

    $11.39M

    -24.41%

  • Total liabilities

    $5.95M

    -22.30%

  • Total investments

    $7.19M

    -33.54%

  • Shareholders' equity

    $5.44M

    -26.60%

  • Book value per share

    $1.37

    -81.80%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$2.35M

    -21.97%

  • Operating expense

    $2.53M

    18.95%

  • Gross profit

    $0

    0%

  • EBITDA

    -$2.32M

    -22.32%

  • Earnings per share

    -

    -


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    $271.62K

    117.02%

  • Cash from operations

    -$2.18M

    -64.91%

  • Cash from investing

    $2.60M

    316685.75%

  • Cash from financing

    -$149.89K

    45.49%

  • Free cash flow

    -$2.18M

    -64.91%

  • Free cash flow per share

    -$0.55

    59.07%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $1.96M

    -52.11%

  • Enterprise value

    -$883.00K

    -33.35%

  • Shares outstanding

    3.98M

    303.15%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    -

    -

  • Coverage ratio

    -

    -

  • Current ratio

    3.02

    -2.11%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.